A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
Back
9 Feb 2025
9:36 a.m.
9:54 a.m.
Jonathan
Barratt
Oral Abstract Presenter
United Kingdom
University of Leicester, Leicester, UK